7Baggers
 erasca files $500m mixed securities shelf  MSN Mon, 29 Sep 2025 07:44:16 GMT
 erasca, inc. (nasdaq:eras) receives $3.71 consensus pt from analysts  Defense World Fri, 26 Sep 2025 07:04:43 GMT
 Wall Street Zen Upgrades Erasca (NASDAQ:ERAS) to Hold  Defense World Sun, 21 Sep 2025 07:25:05 GMT
 erasca (nasdaq:eras) rating lowered to "sell" at wall street zen  MarketBeat Thu, 18 Sep 2025 02:34:57 GMT
 erasca (nasdaq:eras) rating lowered to "sell" at wall street zen  MarketBeat Wed, 17 Sep 2025 21:53:58 GMT
 erasca (nasdaq:eras) rating lowered to sell at wall street zen  MarketBeat Wed, 17 Sep 2025 06:05:10 GMT
 erasca (nasdaq:eras) rating lowered to sell at wall street zen  MarketBeat Tue, 16 Sep 2025 07:00:00 GMT
 Erasca (NASDAQ:ERAS) Downgraded by Wall Street Zen to Sell  beritasriwijaya.co.id Mon, 15 Sep 2025 07:00:00 GMT
 erasca (nasdaq:eras) stock rating lowered by wall street zen  MarketBeat Mon, 15 Sep 2025 05:59:26 GMT
 spotlight on september 2025's promising penny stocks  simplywall.st Fri, 12 Sep 2025 07:00:00 GMT
 published on: 2025-09-09 05:40:52  Newser Tue, 09 Sep 2025 10:40:52 GMT
 erasca, inc. $eras shares sold by american century companies inc.  MarketBeat Tue, 09 Sep 2025 07:17:59 GMT
 483,583 shares in erasca, inc. $eras bought by nuveen llc  MarketBeat Tue, 09 Sep 2025 07:00:00 GMT
 erasca's (eras) underperform rating reiterated at bank of america  MarketBeat Mon, 08 Sep 2025 07:00:00 GMT
 nuveen llc takes position in erasca, inc. $eras  Defense World Thu, 04 Sep 2025 08:37:30 GMT
 wall street zen upgrades erasca (nasdaq:eras) to "hold"  MarketBeat Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-09-04 00:19:00  Newser Thu, 04 Sep 2025 05:19:00 GMT
 erasca double downgraded to underperform at bofa  MSN Thu, 04 Sep 2025 02:37:13 GMT
 erasca, candle, xencor drop as bofa downgrades (eras:nasdaq)  Seeking Alpha Wed, 03 Sep 2025 19:14:48 GMT
 bofa securities downgrades erasca to underperform  MarketScreener Wed, 03 Sep 2025 12:14:20 GMT

Erasca Inc
(NASDAQ:ERAS) 

ERAS stock logo

Erasca is a clinical-stage, precision oncology company with a bold mission—to erase cancer. ... Our robust, rapidly advancing pipeline of promising therapeutic candidates has the potential to improve the treatment of a range of RAS/MAPK pathway-related cancers—and in turn, transform millions of live...

Founded: 2018
Full Time Employees: 102
CEO / Co-Founder: Jonathan E. Lim 
Sector:
Industry:

Share this website to your friends